4579.T

RaQualia Pharma Inc. [4579.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

4579.T Stock Summary

Top 10 Correlated ETFs

4579.T


Top 10 Correlated Stocks

4579.T


In the News

4579.T Financial details

Company Rating
Buy
Market Cap
15.63B
Income
279.38M
Revenue
2.48B
Book val./share
300.65
Cash/share
176.52
Dividend
-
Dividend %
-
Employees
65
Optionable
No
Shortable
Yes
Earnings
09 Nov 2023
P/E
57.48
Forward P/E
-
PEG
-9.13
P/S
6.46
P/B
2.47
P/C
4.17
P/FCF
-178457.87
Quick Ratio
14.46
Current Ratio
14.77
Debt / Equity
0.04
LT Debt / Equity
0.03
-
-
EPS (TTM)
13.37
EPS next Y
-
EPS next Q
-
EPS this Y
-4.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
31.41%
Revenue Q/Q
73.71%
EPS Q/Q
-217.15%
-
-
-
-
SMA20
-3.2%
SMA50
1.84%
SMA100
-8.56%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.02%
Gross Margin
90%
Oper. Margin
6%
Profit Margin
11%
Payout
-
Shs Outstand
21.62M
Shs Float
17.63M
-
-
-
-
Target Price
-
52W Range
663.0-1421.0
52W High
-48.21%
52W Low
+11.01%
RSI
48.84
Rel Volume
0.54
Avg Volume
134.73K
Volume
72.3K
Perf Week
-1.21%
Perf Month
2.36%
Perf Quarter
-12.17%
Perf Half Y
-10.9%
-
-
-
-
Beta
0.834459
-
-
Volatility
11.61%, 15.99%
Prev Close
-1.47%
Price
736
Change
-1.08%

4579.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
Revenue per share
36.5582.7152.85132.5139.16
Net income per share
-54.230.26-28.9736.0734.5
Operating cash flow per share
-19.83-25.78-13.817.4770.58
Free cash flow per share
-30.69-30.37-21.2712.4469.06
Cash per share
90.31106.86100.88126.91187.23
Book value per share
189.36224.42191.46228.51262.14
Tangible book value per share
187.69222.85189.88226.9260.98
Share holders equity per share
189.36224.42191.46228.51262.14
Interest debt per share
0.150.122.191.9310.89
Market cap
21.94B27.61B20.95B24.6B25.83B
Enterprise value
20.27B25.44B19.6B22.29B22.38B
P/E ratio
-19.865.17K-34.5232.5535.71
Price to sales ratio
29.4616.2118.928.868.85
POCF ratio
-54.3-52.01-72.4467.2117.45
PFCF ratio
-35.09-44.16-47.0294.3917.84
P/B Ratio
5.695.985.225.144.7
PTB ratio
5.695.985.225.144.7
EV to sales
27.2214.9417.78.037.67
Enterprise value over EBITDA
-21.67222.73-48.5521.9221.21
EV to operating cash flow
-50.17-47.92-67.7860.915.12
EV to free cash flow
-32.42-40.69-43.9985.5415.45
Earnings yield
-0.050-0.030.030.03
Free cash flow yield
-0.03-0.02-0.020.010.06
Debt to equity
000.010.010.04
Debt to assets
000.010.010.04
Net debt to EBITDA
1.78-19.023.34-2.27-3.27
Current ratio
11.9316.7515.18109.77
Interest coverage
00-1.11K486.84144.49
Income quality
0.37-19.440.550.421.74
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.880.350.470.220.2
Research and developement to revenue
1.440.510.840.410.43
Intangibles to total assets
0.010.010.010.010
Capex to operating cash flow
0.550.180.54-0.29-0.02
Capex to revenue
-0.3-0.06-0.14-0.04-0.01
Capex to depreciation
-1.76-0.67-1.26-0.74-0.22
Stock based compensation to revenue
00000
Graham number
480.6736.2353.28430.65451.08
ROIC
-0.290-0.140.120.12
Return on tangible assets
-0.270-0.140.150.12
Graham Net
83.88126.47111.68152.82179.8
Working capital
1.8B2.88B2.65B3.6B4.33B
Tangible asset value
3.82B4.59B3.98B4.75B5.47B
Net current asset value
1.77B2.85B2.59B3.56B4.06B
Invested capital
000.010.010.04
Average receivables
390.99M451.9M719.96M964.6M1.06B
Average payables
992K17.15M38.06M43.91M87.03M
Average inventory
5.83M6M6.02M8.54M9.52M
Days sales outstanding
39.88176.28203.54172.46100.16
Days payables outstanding
047.63110.6352.35201.84
Days of inventory on hand
26.537.6417.31213.4
Receivables turnover
9.152.071.792.123.64
Payables turnover
07.663.36.971.81
Inventory turnover
13.7647.7821.130.427.25
ROE
-0.290-0.150.160.13
Capex per share
-10.86-4.58-7.46-5.03-1.52

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
Revenue per share
13.765.6848.3417.1729.78
Net income per share
7.33-0.0312.22-6.888.04
Operating cash flow per share
2.954.2625.15-9.76-23.35
Free cash flow per share
2.794.0824.9-11.32-28.07
Cash per share
41.4346.63187.23210.01176.52
Book value per share
65.3165.16262.14289.74300.65
Tangible book value per share
64.9564.82260.98288.02299.07
Share holders equity per share
65.3165.16262.14289.74300.65
Interest debt per share
3.163.0110.6912.1511.49
Market cap
56.76B84.06B25.83B18.08B15.97B
Enterprise value
53.85B80.74B22.38B14.07B12.67B
P/E ratio
24.04-9.04K25.21-30.4622.97
Price to sales ratio
51.23183.8825.4848.824.82
POCF ratio
239.32245.1148.99-85.82-31.65
PFCF ratio
252.46255.7149.48-74.02-26.33
P/B Ratio
10.7916.024.72.892.46
PTB ratio
10.7916.024.72.892.46
EV to sales
48.6176.6322.0837.9719.69
Enterprise value over EBITDA
65.51-118.92K87.75-189.5158.06
EV to operating cash flow
227.04235.4542.45-66.78-25.11
EV to free cash flow
239.5245.6342.87-57.6-20.89
Earnings yield
0.0100.01-0.010.01
Free cash flow yield
000.02-0.01-0.04
Debt to equity
0.050.050.040.040.04
Debt to assets
0.040.040.040.040.03
Net debt to EBITDA
-3.544.88K-13.5454.03-15.11
Current ratio
10.5613.059.7714.114.77
Interest coverage
358.97-29.9123.78-72.2656.22
Income quality
0.31-102.342.961.91-3.44
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.110.290.170.410.25
Research and developement to revenue
0.240.680.40.720.52
Intangibles to total assets
0000.010
Capex to operating cash flow
-0.05-0.04-0.010.160.2
Capex to revenue
-0.01-0.03-0.01-0.09-0.16
Capex to depreciation
-0.33-0.37-0.13-1.08-2.5
Stock based compensation to revenue
00000
Graham number
103.816.51268.46211.74233.27
ROIC
0.09-0.010.05-0.020.01
Return on tangible assets
0.100.04-0.020.02
Graham Net
43.5246.13179.8199.74188.77
Working capital
4.1B4.24B4.33B4.92B4.86B
Tangible asset value
5.23B5.22B5.47B6.21B6.46B
Net current asset value
3.86B3.99B4.06B4.59B4.51B
Invested capital
0.050.050.040.040.04
Average receivables
886.58M934.42M772.89M720.65M965M
Average payables
57.29M63.07M99M94.84M64.98M
Average inventory
8.96M8.76M8.84M8.53M8.47M
Days sales outstanding
91.29146.6871.09155.6180.32
Days payables outstanding
98.4599.3181.2293.3197.87
Days of inventory on hand
14.6213.0312.0312.9811.98
Receivables turnover
0.990.611.270.580.5
Payables turnover
0.910.910.50.960.92
Inventory turnover
6.156.917.486.947.51
ROE
0.1100.05-0.020.03
Capex per share
-0.15-0.18-0.25-1.56-4.72

4579.T Frequently Asked Questions

What is RaQualia Pharma Inc. stock symbol ?

RaQualia Pharma Inc. is a JP stock and trading under the symbol 4579.T

What is RaQualia Pharma Inc. stock quote today ?

RaQualia Pharma Inc. stock price is $736 today.

Is RaQualia Pharma Inc. stock public?

Yes, RaQualia Pharma Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks